SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is trending amid speculation around potential connections to Elon Musk's Grok AI. The community is also excited about the project's fundamentals, including its zero-tax setup, and a potential listing on Binance. Many participants are expressing bullish sentiment, using terms like "WAGMI" and "To The Moon".

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community celebrates its joke-inspired roots and long-term presence on the Solana blockchain. Many are drawn to its dedicated community, locked liquidity, and association with the popular "What's UpDog?" meme, while others highlight its potential within the broader meme coin landscape.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE.X is trending amidst community enthusiasm, fueled by its meme-centric nature and comparisons to other successful meme coins. Community members are actively encouraging each other to 'RAGE HARDER' and expressing strong bullish sentiment, while also highlighting growing community and potential for significant gains. The coin is also getting attention from influencers.

Pump.fun

PUMP.X is trending as community members discuss its potential within the Solana ecosystem, particularly alongside tokens like WAGMI. Bullish sentiment seems to be fueled by the platform's mechanics around token buybacks and creator rewards. Some traders are closely watching key support and resistance levels, anticipating potential breakouts.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter ($JUP.X) is trending due to community excitement around its connection to the Solana-based meme coin $UPDOG.X, which is exclusively listed on Jupiter's strict list, driving users to swap $SOL.X for $UPDOG.X on the platform. The community buzz highlights the relentless work of the UpDog team and anticipates a wave of bullishness for this joke meta pioneer.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as buyers aim for further gains, fueled by bullish sentiment and strong chart signals. The community is buzzing about the company's momentum and technical setup, especially after the recent acquisition that expands its anticoagulant pipeline. With growing interest in its healthcare technology niche, traders are closely watching for a potential breakout.

Mamo turns what used to be complex into easy, human-first routines.  It works quietly in the background, finding smart opportunities for your money while you focus on what matters in your life. Think of Mamo as your knowledgeable friend who understands how to help your money grow and explain everything in plain language.  Behind the scenes, Mamo applies proven strategies and real-time data to optimize your portfolio, reinvest earnings when conditions are right, and adapt to market shifts — all with your approval and full transparency.  No noise. No confusion. Just calm, steady growth.

Mamo

MAMO.X is trending as users discuss its potential for high yields and AI-driven functionality, particularly within the Base ecosystem. Speculation around a potential Coinbase listing and integration with the Base App is fueling community excitement. Some users are also comparing it to other Base projects and discussing entry points amid price fluctuations.

FFFFFFFFFFFFFUUUUUUUUUUUUUUUU

$RAGEGUY.X is trending as the community discusses its recent price action and potential for further gains, with some users reporting significant increases. The conversation highlights community excitement and speculation around potential 'V-shape recovery coding'. Mentions of related tokens like $UPDOG.X and $401JK.X are also contributing to the increased interest.

Codatta

Codatta ($XNY.X) is trending amid discussions about its on-chain fingerprint verification launch and potential use of AI. The community is analyzing its chart patterns, highlighting key support zones and bullish setups, while also debating potential pullbacks and entry points. Some users are pointing to its strong performance compared to the broader market.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is trending due to positive Phase 2a results for its COVID-19 treatment, EDP-323, leading to community excitement and discussions about the drug's potential. The company's broader pipeline, particularly in RSV antivirals, adds to the positive sentiment, though some analysts remain cautious, pointing to mixed financial metrics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Do Options Traders Know Something About CareDx Stock We Don't?

Investors need to pay close attention to CDNA stock based on the movements in the options market lately.

Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings

The headline numbers for CareDx (CDNA) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates

CareDx (CDNA) delivered earnings and revenue surprises of -16.67% and -4.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?

CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Is IDEXX Laboratories Stock Underperforming the Nasdaq?

Despite IDEXX Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict

CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

Johnson Fistel, LLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for potential breaches of...

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...

CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies

CareDx to Report Fourth Quarter and Full Year 2024 Financial Results

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Caredx Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$14.93
Prev Close	$14.87
Open	$14.88
Dividend Yield	0.00%
50-Day Moving Average	$13.13
Beta	1.33
Avg. Volume	1.47M
PE Ratio	14.62

52-Week High	$32.97
52-Week Low	$10.96
Market Capitalization	$794.68M
EPS (Annual)	$0.9281
Price to Book	2.43
Revenue Per Employee	$513,515.39
Enterprise Value/EBITDA	N/A

CDNA
Caredx Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CDNA News

CDNA Caredx Inc